Patients with oropharyngeal squamous cell carcinoma (OPSCC) and human papillomavirus (HPV) are largely unaware of a possible link between the two conditions, according to a

Some 35% to 60% of all patients with head and neck cancers (HNC) are malnourished when they are diagnosed, according to a new study in

European researchers have identified unique DNA markings that may predict the risk of developing head and neck cancer, according to a study in the journal

An overwhelming majority of people in the U.K. support the human papillomavirus (HPV) vaccination for boys, according to a survey conducted by OnePoll on behalf

Low-level laser therapy (LLLT) has shown promising results in reducing the occurrence of canker sores in head and neck squamous cell carcinoma (HNSCC) patients undergoing

Magnetic resonance imaging (MRI) may be a better tool for predicting the chances of survival and tumor metastasis of patients with oral cancer, according to

Offering free head and neck cancer (HNC) screenings annually to communities offers the possibility of early detection and the opportunity to increase the understanding of

Head and neck cancer (HNC) patients who are hospitalized after surgery and do not receive anticoagulation therapy have an increased risk of blood clots, according

Young patients with recurrent squamous cell carcinoma (SCC) of the tongue have 100% fatality rates within 16 months of its appearance compared with a 50%

The aging baby boomer generation is bringing with it a number of healthcare concerns, among them an anticipated rise in cancer rates and osteoporosis diagnoses.

Oropharyngeal carcinoma patients treated with intensity-modulated proton therapy (IMPT) were half as likely to need feeding tubes compared to patients treated with intensity-modulated radiation therapy

The precise targeting and limited dosing of radiation via proton therapy can reduce treatment side effects among head and neck cancer (HNC) patients, according to